Ibrunat 140 Mg Capsules

Product Description

Ibrunat Capsule is taken in a dose as advised by the doctor. The duration of treatment varies on the basis of your response to treatment. Your doctor may get regular blood tests to check number of blood cells during treatment with this medicine. It is known to reduce the number of blood cells in your blood thereby, increasing the susceptibility to infections.  It may cause headache, diarrhea, and nausea as its side effects.

Targeted Therapy for Blood Cancers

Ibrunat 140 Mg Capsules are specifically formulated to inhibit Bruton's tyrosine kinase, providing effective treatment for certain blood cancers. This targeted mechanism aids in reducing cancer progression in conditions such as CLL, MCL, and Waldenstrom's Macroglobulinemia, making it a vital option for adult patients needing advanced antineoplastic therapy.


Patient-Centric Dosage and Administration

Designed for oral administration, Ibrunat simplifies the cancer treatment process with a straightforward daily regimen, as prescribed by a healthcare provider. Each capsule contains a controlled 140 mg dose of Ibrutinib, ensuring patient compliance and optimal efficacy. Always follow your physician's instructions for best results.


Safe Handling and Storage Guidelines

To maintain efficacy, store Ibrunat capsules below 30C in a dry environment, protected from light. Always check the expiry date on the package before use, and keep the medicine out of reach of children. Adhere to storage instructions for the complete shelf life of 24 months from manufacture date.